NCT06465992
Liposomal Bupivacaine With Dexamethasone for Foot Surgery
UNKNOWN
PHASE4Ages 18+InterventionalTreatmentRothman Institute OrthopaedicsInvestigator-initiated
~126 participants
Updated 2024-06-20 on ClinicalTrials.gov
What's tested:Exparel 266 MG Per 20 ML InjectionBupivacaine Hcl 0.75% InjDexamethasone
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Amount of pain medication used after surgery
Measured over 14 days
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Participants with foot and ankle procedures at Jefferson Surgery Center, Navy Yard
Participants with foot and ankle orthopedic procedures requiring a preoperative nerve block
Age 18 and older
English speaking
Ability to complete surveys by phone or in person
Ability to provide informed consent
Exclusion
Revision foot and ankle cases
Allergies to study medications
Non-English speakers
Known alcohol or narcotic abuse history
Existing contract with a pain specialist due to underlying preoperative pain syndrome
Preoperative opioid use within the 3 months prior to surgery
Participants who are pregnant, plan to become pregnant, or are breastfeeding.
What this trial measures
- Amount of pain medication used after surgery14 days
Collected as tablets taken since all participants will be prescribed oxycodone
- Pain level after surgery14 days
Participants will be asked daily what their pain levels are using the Visual Analog (VAS) pain scale